Chemical process development bridges drug discovery and active pharmaceutical ingredient (API) manufacturing by enabling rapid, safe, sustainable, and cost-effective access to new chemical modalities. A key objective is to design robust processes that reduce resource consumption, waste generation, and reliance on hazardous chemicals while improving safety, environmental performance, and manufacturability. As sustainability becomes an essential expectation for the pharmaceutical industry, it must be integrated early in portfolio development rather than considered only at later stages. This presentation will highlight selected initiatives to advance sustainability in early-stage API synthesis and demonstrate their impact on more responsible and efficient chemical development.
Speakers
Trung Cao
Johnson & Johnson
Belgium
Event details
Chemical process development bridges drug discovery and active pharmaceutical ingredient (API) manufacturing by enabling rapid, safe, sustainable, and cost-effective access to new chemical modalities. A key objective is to design robust processes that reduce resource consumption, waste generation, and reliance on hazardous chemicals while improving safety, environmental performance, and manufacturability. As sustainability becomes an essential expectation for the pharmaceutical industry, it must be integrated early in portfolio development rather than considered only at later stages. This presentation will highlight selected initiatives to advance sustainability in early-stage API synthesis and demonstrate their impact on more responsible and efficient chemical development.